ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,168Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 16

$423K Total Retail Price of All Prescriptions

Rank: 3 out of 16

377 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 377 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 377 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

5% of this provider’s 9,742 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
POTASSIUM CHLORIDE 598 561 1 11
AMLODIPINE BESYLATE 565 524 2 4
LEVOTHYROXINE SODIUM 477 425 3 1
FUROSEMIDE 437 422 4 8
HYDROCHLOROTHIAZIDE 348 305 5 9
LISINOPRIL 340 319 6 2
NABUMETONE 317 237 7 20
HYDROCODONE-ACETAMINOPHEN 295 260 S3 8 3
WARFARIN SODIUM 253 232 9 12
SIMVASTATIN 238 223 10 5
METFORMIN HCL 236 196 11 6
GUANFACINE HCL 218 217 R 12 28
METOPROLOL TARTRATE 197 172 13 15
GABAPENTIN 195 168 14 10
TAMSULOSIN HCL 163 142 15 22
ALLOPURINOL 160 143 16 21
OMEPRAZOLE 158 113 17 7
GLYBURIDE 156 133 R 18 42
TRAMADOL HCL 150 132 19 23
ATORVASTATIN CALCIUM 140 119 20 13
DIGOXIN 133 128 21 47
ALENDRONATE SODIUM 129 129 22 14
TRIAMTERENE-HCTZ 128 128 23 48
PREDNISONE 121 107 24 51
DONEPEZIL HCL 105 105 25 40
PAROXETINE HCL 103 74 26 31
ZOLPIDEM TARTRATE 100 96 27 27
CEPHALEXIN 97 89 28 37
SYNTHROID 97 97 28 57
OXYCODONE-ACETAMINOPHEN 93 61 S2 30 61
PROBENECID 85 80 31 64
BISOPROLOL-HYDROCHLOROTHIAZIDE 77 72 32 67
DILTIAZEM 24HR CD 76 65 33 68
SINGULAIR 75 74 34 69
FINASTERIDE 72 72 35 38
CELEBREX 71 71 36 74
TERAZOSIN HCL 68 56 37 77
CLONIDINE HCL 66 55 38 35
ADVAIR DISKUS 65 50 39 30
SULFAMETHOXAZOLE-TRIMETHOPRIM 65 48 39 79
CLOPIDOGREL 56 49 41 86
AMOXICILLIN 56 48 41 86
ESCITALOPRAM OXALATE 55 51 43 88
TRIAMCINOLONE ACETONIDE 54 48 44 90
FENTANYL 54 54 S2 44 49
JANUVIA 54 54 44 49
NEXIUM 54 24 44 26
FLUTICASONE PROPIONATE 50 47 48 16
ISOSORBIDE MONONITRATE ER 50 50 48 56
VENLAFAXINE HCL 50 50 48 101
VERAPAMIL ER 50 38 48 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 9, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.